In Situ Albumin-Hitchhiking NIR-II Probes for Accurate Detection of Micrometastases.
Youcui XuChang YangYi WuWei JiangQuan ChengLifeng YanKaige ChenYu-Cai WangPublished in: Nano letters (2023)
Tumor metastasis remains the primary cause of treatment failure in cancer patients, and the high-sensitivity preoperative and intraoperative detection of occult micrometastases continues to pose a notorious challenge. Therefore, we have designed an in situ albumin-hitchhiking near-infrared window II (NIR-II) fluorescence probe, IR1080, for the precise detection of micrometastases and subsequent fluorescence image-guided surgery. IR1080 rapidly covalently conjugates with albumin in plasma, resulting in a stronger fluorescence brightness upon binding. Moreover, the albumin-hitchhiked IR1080 has a high affinity for secreted protein acidic and rich in cysteine (SPARC), an albumin-binding protein that is overexpressed in micrometastases. The interaction between SPARC and IR1080-hitchhiked albumin enhances IR1080's capacity to track and anchor micrometastases, leading to a high detection rate and margin delineation ability, as well as a high tumor-to-normal tissue ratio. Therefore, IR1080 represents a highly efficient strategy for the diagnosis and image-guided resection surgery of micrometastases.
Keyphrases
- loop mediated isothermal amplification
- binding protein
- highly efficient
- single molecule
- label free
- minimally invasive
- real time pcr
- photodynamic therapy
- living cells
- fluorescent probe
- patients undergoing
- coronary artery bypass
- drug delivery
- transcription factor
- fluorescence imaging
- energy transfer
- high resolution
- sensitive detection
- combination therapy
- quantum dots
- cancer therapy
- amino acid